Repeated Fecal Occult Blood Test Positivity Is Associated With Clinically Significant Colonoscopic Findings
The European Research Journal · 01.12.2026 · 1408-1415
DOI: 10.18621/eurj.1295 ↗Kurz gefasst
Fachartikel in der Zeitschrift The European Research Journal, online erschienen am 01.12.2026. Verfasst von Halit Kandemir und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate the association between repeated guaiac-based fecal occult blood test (gFOBT) positivity and clinically significant colonoscopic and histopathological findings, particularly colorectal malignancy.
Methods
This retrospective, single-center cohort study included patients with positive gFOBT results at the Gastroenterology Outpatient Clinic of Gazi University Faculty of Medicine between June 2017 and October 2025. Patients were categorized into 3 groups based on gFOBT results: single positive (Group 1), 2 consecutive positive tests within 1 month (Group 2), and an initial positive followed by a negative test within 1 month (Group 3). Colonoscopic and histopathological findings were compared between groups. Multivariable logistic regression analysis was conducted to identify independent predictors of malignant pathology.
Results
Of 1442 patients with positive gFOBT results, 735 (50.9%) underwent diagnostic colonoscopy. Colorectal malignancy was detected in 55 patients (7.5%) undergoing colonoscopy. Malignancy rates differed significantly among groups: 5.1% in Group 1, 17.4% in Group 2, and 0% in Group 3 (P < .001). Repeated gFOBT positivity was independently associated with malignant findings (odds ratio [OR], 3.68; 95% CI, 2.03 to 6.69; P < .001). Normal findings were significantly more frequent in patients with a single positive test, whereas malignant findings were markedly higher in patients with repeated positivity.
Conclusions
Repeated gFOBT positivity is strongly associated with clinically significant colonoscopic pathology, particularly colorectal malignancy. Patients with consecutive positive gFOBT results represent a high-risk subgroup and should be prioritized for prompt diagnostic colonoscopy within colorectal cancer screening programs.
Zitieren
APA
Kandemir, H., Kılıç, G., Karataş, A., Demir, B., Cömert, E., Kirman, D., Kalkan, Ç., Kekilli, M., Karakan, T., & Cindoruk, M. (2026). Repeated Fecal Occult Blood Test Positivity Is Associated With Clinically Significant Colonoscopic Findings. The European Research Journal, 1408-1415. https://doi.org/10.18621/eurj.1295
Vancouver
Kandemir H, Kılıç G, Karataş A, Demir B, Cömert E, Kirman D, et al. Repeated Fecal Occult Blood Test Positivity Is Associated With Clinically Significant Colonoscopic Findings. The European Research Journal. 2026:1408-1415. doi:10.18621/eurj.1295
BibTeX
@article{Kandemir2026,
author = {Kandemir, Halit and Kılıç, Güner and Karataş, Ali and Demir, Beril and Cömert, Enes and Kirman, Derya and Kalkan, Çağdaş and Kekilli, Murat and Karakan, Tarkan and Cindoruk, Mehmet},
title = {Repeated Fecal Occult Blood Test Positivity Is Associated With Clinically Significant Colonoscopic Findings},
journal = {The European Research Journal},
year = {2026},
pages = {1408--1415},
doi = {10.18621/eurj.1295}
}
EUVIMED